GlassScriptPhysician profile
Brielle Robin Hebert
NPI 1366897035
$21,753.31
in general payments reported to CMS, 2019-2025
7 companies · $582 in 2025
The $582 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.40 · 2022: $20K · 2023: $1,241 · 2024: $305 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $847 · Travel and Lodging: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $846.89 |
| Travel and Lodging | $281.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $20,786.25 | 2021-2025 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $448.60 | 2022-2025 | Interstim, Endoflip |
| Ethicon US, LLC | $355.01 | 2024-2025 | Echelon; Endopath, Endopath, Dermabond |
| Karl Storz Endoscopy-America | $89.95 | 2022-2023 | Hopkins, Radiance |
| Conmed Corporation | $33.33 | 2023 | Airseal |
| Pacira Pharmaceuticals Incorporated | $20.17 | 2022 | |
| Davol INC. | $20.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brielle Hebert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.